These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16375693)

  • 1. The new immunosuppression: intervention at the dendritic cell-T-cell interface.
    Paterson AM; Yates SF; Nolan KF; Waldmann H
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):397-411. PubMed ID: 16375693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and the induction of tolerance by dendritic cells.
    Buckland M; Lombardi G
    Handb Exp Pharmacol; 2009; (188):197-213. PubMed ID: 19031027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Window of opportunity for daclizumab.
    Schluns KS
    Nat Med; 2011 May; 17(5):545-7. PubMed ID: 21546970
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection.
    Ge W; Arp J; Lian D; Liu W; Baroja ML; Jiang J; Ramcharran S; Eldeen FZ; Zinser E; Steinkasserer A; Chou P; Brand S; Nicolette C; Garcia B; Wang H
    Transplantation; 2010 Dec; 90(11):1145-56. PubMed ID: 20861805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerogenic dendritic cells and their role in transplantation.
    Ezzelarab M; Thomson AW
    Semin Immunol; 2011 Aug; 23(4):252-63. PubMed ID: 21741270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
    Seldon TA; Pryor R; Palkova A; Jones ML; Verma ND; Findova M; Braet K; Sheng Y; Fan Y; Zhou EY; Marks JD; Munro T; Mahler SM; Barnard RT; Fromm PD; Silveira PA; Elgundi Z; Ju X; Clark GJ; Bradstock KF; Munster DJ; Hart DN
    Leukemia; 2016 Mar; 30(3):692-700. PubMed ID: 26286117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.
    Turnquist HR; Thomson AW
    Curr Opin Organ Transplant; 2008 Aug; 13(4):350-7. PubMed ID: 18685329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells as pharmacological targets for the generation of regulatory immunosuppressive effectors. New implications for allo-transplantation.
    Schlichting CL; Schareck WD; Nickel T; Weis M
    Curr Med Chem; 2005; 12(16):1921-30. PubMed ID: 16101510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell tolerance in transplantation: possibilities for therapeutic intervention.
    Cobbold SP
    Expert Opin Ther Targets; 2002 Oct; 6(5):583-99. PubMed ID: 12387682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity.
    Chatenoud L
    Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.
    Adorini L; Giarratana N; Penna G
    Semin Immunol; 2004 Apr; 16(2):127-34. PubMed ID: 15036236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells,tolerance and therapy of organ allograft rejection.
    Raimondi G; Thomson AW
    Contrib Nephrol; 2005; 146():105-120. PubMed ID: 15567925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.
    Hackstein H; Thomson AW
    Nat Rev Immunol; 2004 Jan; 4(1):24-34. PubMed ID: 14704765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice.
    Zou S; Shen X; Tang Y; Fu Z; Zheng Q; Wang Q
    Transplant Proc; 2010 Nov; 42(9):3798-802. PubMed ID: 21094859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic dendritic cell therapy in organ transplantation.
    Moreau A; Alliot-Licht B; Cuturi MC; Blancho G
    Transpl Int; 2017 Aug; 30(8):754-764. PubMed ID: 27864897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting DEC-205
    Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
    Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.